Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-16

Clinical Trial Update: Healing Study of Fractional Skin Resurfacing and Tissue Histopathology After Ellacor Treatment [NA]

View source ↗

Summary

Completed clinical trial evaluating healing and tissue histopathology after Ellacor fractional skin resurfacing. The study targeted wrinkles and rhytides and wa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ellacor

Snippet

Sponsor: Cytrellis Biosystems, Inc. | Conditions: Wrinkle, Rhytides | NA | Status: COMPLETED